ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

Asks BSC For Advice On Centers Funding, Other Pressing Issues, But Doesn’t Get Any

March 30, 1990

Stephen Gruber Named Director at USC Norris; TGen and Cedars-Sinai to Coordinate Phase I Trials.

October 21, 2011

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997